This public procurement record has 1 release in its history.

Award

20 Jul 2022 at 16:07

Summary of the contracting process

The procurement process is focused on the NHS National Framework Agreement for the supply of products for managing Hereditary Angioedema, led by NHS England. The contract is categorised under pharmaceutical products, specifically involving plasma extracts and blood products. This open tender process is currently complete and commenced on 1 July 2022, with a deadline for submissions that ended on 16 March 2022. The contract is set to last until 31 December 2023, with a possible extension period of up to 30 months, amounting to a total maximum value of £74,500,000. The products will be delivered to various regions across the United Kingdom including Scotland, Northern Ireland, England, and also to the Isle of Man, Guernsey, and Jersey.

This tender presents significant opportunities for businesses, especially those specialising in pharmaceutical goods, particularly in areas related to blood products and plasma extracts. Small and medium-sized enterprises (SMEs) are encouraged to participate, given the emphasis on SME suitability within this contract. Businesses with relevant expertise in pharmaceutical supply chains, production capabilities for specialty medicines, or those already engaged in health-related supplies will be well-placed to compete for this lucrative framework agreement.

How relevant is this notice?

Notice Title

Hereditary Angioedema

Notice Description

NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-5242c430-9651-453d-9ccd-71a66de32b6f
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/1132440f-b206-4c8a-9c65-84276d8d2f77
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33141510 - Blood products

33141520 - Plasma extracts

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£74,500,000 £10M-£100M
Lots Value
Not specified
Awards Value
£74,500,000 £10M-£100M
Contracts Value
Not specified

Notice Dates

Publication Date
20 Jul 20224 years ago
Submission Deadline
16 Mar 2022Expired
Future Notice Date
Not specified
Award Date
20 Jun 20224 years ago
Contract Period
1 Jul 2022 - 31 Dec 2023 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England

Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England), TLM Scotland, TLN Northern Ireland

Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
10
Supplier Names

Martindale Pharma

Piramal Critical care Limited

CSL Behring UK Ltd

Wockhardt UK Limited

Cipla (EU) Limited

Takeda UK Limited

BioCryst Ireland Limited

Pharming Group

Accord-UK Ltd

Celix Pharma Ltd.

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...